Myositis and acute respiratory infection.

formulation as blue-coloured, sweet-tasting tablets, and in the fact that it is prescribed for migraine, a relatively non-serious disease. Dixarit is probably regarded as a non-dangerous drug, being stored in places accessible to children, while, by contrast, the antihypertensive Catapres is treated with appropriate respect. We hope that this article will alert doctors prescribing Dixarit so that they can issue appropriate warnings to parents to keep this drug out of the reach of young children. When the size of this problem became known, the manufacturers alerted pharmacists through a letter published in the Pharmaceutical Journal,5 and, more recently, a warning has been incorporated in the label on the standard package for Dixarit. As yet, we have detected no decrease in the rate of new cases, possibly because the new labels did not reach all retailers until late 1977. Probably, however, further measures will be needed, and safety packaging is being considered.